Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank 薬物名（臨床試験情報から抽出） KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Paricalcitol 1件: Paricalcitol1件: Paricalcitol; 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬5件: 19, 66, 218, 238, 298
2 Alfacalcidol 1件: Alfacalcidol2件: ALFACALCIDOL; One-alpha; 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬8件: 41, 46, 49, 50, 96, 107, 235, 238
3 Cinacalcet 1件: Cinacalcet1件: Cinacalcet; 1件: CASR 💬2件: NOD-like receptor signaling pathway, Parathyroid hormone synthesis, secretion and action 💬1件: 238
4 Sevelamer 1件: Sevelamer1件: Sevelamer; --2件: 235, 238
5 Burosumab 1件: Burosumab1件: Burosumab; 1件: FGF23 💬11件: Breast cancer, Calcium signaling pathway, Gastric cancer, MAPK signaling pathway, Melanoma, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton 💬1件: 238